Generics

Fluoxetine tablets, 10 mg and 20 mg, had a market value of roughly $53 million, according to IQVIA June 2019 data.

Lannett expects to commercialize products in the oncolytic and hormonal therapeutic categories, including injectables, that are within Cediprof's development and manufacturing capabilities.

Fulvestrant injection, 250 mg/5 mL (50 mg/mL) had a market value of approximately $549.9 million for the 12 month period ending June 2019, according to IQVIA.

Zydus Cadila's ranolazine tablets will be available in a dosage strength of 500 mg and 1,000 mg.

Hydrocortisone valerate cream had a market value of roughly $15 million for the year ended March 2019, according to IQVIA.

Unichem Laboratories has received the FDA's nod for a generic treatment for severe pain.

Hikma will manufacture and supply 14 medications for generics company Civica Rx.

Unichem Labs' generic Hygroton is available in two dosage strengths.